• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外受精中最佳胚胎的制作与选择

Making and Selecting the Best Embryo in In vitro Fertilization.

作者信息

Nuñez-Calonge Rocío, Santamaria Nuria, Rubio Teresa, Manuel Moreno Juan

机构信息

Unidad de Reproducción, International Group, Alicante, Spain.

Unidad de Reproducción Mediterráneo, Alicante, Spain.

出版信息

Arch Med Res. 2024 Dec;55(8):103068. doi: 10.1016/j.arcmed.2024.103068. Epub 2024 Aug 26.

DOI:10.1016/j.arcmed.2024.103068
PMID:39191078
Abstract

Currently, most assisted reproduction units transfer a single embryo to avoid multiple pregnancies. Embryologists must select the embryo to be transferred from a cohort produced by a couple during a cycle. This selection process should be accurate, non-invasive, inexpensive, reproducible, and available to in vitro fertilization (IVF) laboratories worldwide. Embryo selection has evolved from static and morphological criteria to the use of morphokinetic embryonic characteristics using time-lapse systems and artificial intelligence, as well as the genetic study of embryos, both invasive with preimplantation genetic testing for aneuploidies (PGT-A) and non-invasive (niPGT-A). However, despite these advances in embryo selection methods, the overall success rate of IVF techniques remains between 25 and 30%. This review summarizes the different methods and evolution of embryo selection, their strengths and limitations, as well as future technologies that can improve patient outcomes in the shortest possible time. These methodologies are based on procedures that are applied at different stages of embryo development, from the oocyte to the cleavage and blastocyst stages, and can be used in laboratory routine.

摘要

目前,大多数辅助生殖单位会移植单个胚胎以避免多胎妊娠。胚胎学家必须从一对夫妇在一个周期内产生的一批胚胎中选择要移植的胚胎。这种选择过程应该准确、无创、廉价、可重复,并且全球的体外受精(IVF)实验室都可以使用。胚胎选择已从静态和形态学标准发展到使用延时系统和人工智能的胚胎形态动力学特征,以及胚胎的遗传学研究,包括侵入性的植入前非整倍体基因检测(PGT-A)和非侵入性的(niPGT-A)。然而,尽管胚胎选择方法有这些进展,IVF技术的总体成功率仍在25%至30%之间。这篇综述总结了胚胎选择的不同方法及其演变、它们的优点和局限性,以及能够在尽可能短的时间内改善患者治疗结果的未来技术。这些方法基于在胚胎发育的不同阶段(从卵母细胞到分裂期和囊胚期)应用的程序,并且可用于实验室常规操作。

相似文献

1
Making and Selecting the Best Embryo in In vitro Fertilization.体外受精中最佳胚胎的制作与选择
Arch Med Res. 2024 Dec;55(8):103068. doi: 10.1016/j.arcmed.2024.103068. Epub 2024 Aug 26.
2
The impact of implementing a non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) embryo culture protocol on embryo viability and clinical outcomes.实施非整倍体无创性胚胎植入前遗传学检测(niPGT-A)胚胎培养方案对胚胎活力和临床结局的影响。
Hum Reprod. 2024 Sep 1;39(9):1952-1959. doi: 10.1093/humrep/deae156.
3
Time will tell: time-lapse technology and artificial intelligence to set time cut-offs indicating embryo incompetence.时间会给出答案:延时技术和人工智能设定时间界限以表明胚胎无发育能力。
Hum Reprod. 2024 Dec 1;39(12):2663-2673. doi: 10.1093/humrep/deae239.
4
Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.体外受精中对非整倍体(染色体数量异常)进行植入前基因检测。
Cochrane Database Syst Rev. 2020 Sep 8;9(9):CD005291. doi: 10.1002/14651858.CD005291.pub3.
5
Clinical validation of an automatic classification algorithm applied on cleavage stage embryos: analysis for blastulation, euploidy, implantation, and live-birth potential.卵裂期胚胎自动分类算法的临床验证:对囊胚形成、整倍体、着床和活产潜能的分析。
Hum Reprod. 2023 Jun 1;38(6):1060-1075. doi: 10.1093/humrep/dead058.
6
Development of an artificial intelligence model for predicting the likelihood of human embryo euploidy based on blastocyst images from multiple imaging systems during IVF.基于体外受精过程中多个成像系统的囊胚图像,开发一种人工智能模型,用于预测人类胚胎整倍体的可能性。
Hum Reprod. 2022 Jul 30;37(8):1746-1759. doi: 10.1093/humrep/deac131.
7
Artificial intelligence system for outcome evaluations of human in vitro fertilization-derived embryos.人工智能系统用于评估人类体外受精胚胎的结局。
Chin Med J (Engl). 2024 Aug 20;137(16):1939-1949. doi: 10.1097/CM9.0000000000003162. Epub 2024 Jul 12.
8
The Relationship Between Abnormal Morphokinetic Embryos, Genetic Testing Results, and Clinical Outcomes.形态动力学异常胚胎、基因检测结果与临床结局之间的关系。
Med Arch. 2025;79(1):4-8. doi: 10.5455/medarh.2025.79.4-8.
9
Multiple collapses of blastocysts after full blastocyst formation is an independent risk factor for aneuploidy - a study based on AI and manual validation.完全囊胚形成后多个囊胚崩溃是非整倍体的独立危险因素——基于人工智能和人工验证的研究。
Reprod Biol Endocrinol. 2024 Jul 15;22(1):81. doi: 10.1186/s12958-024-01242-6.
10
Cumulative live birth rates of 31 478 untested embryos from 11 463 women challenge traditional recurrent implantation failure definitions.来自11463名女性的31478个未经检测胚胎的累积活产率对传统的反复种植失败定义提出了挑战。
Hum Reprod. 2025 May 1;40(5):818-833. doi: 10.1093/humrep/deaf036.

引用本文的文献

1
Assisted Reproductive Technology: A Ray of Hope for Infertility.辅助生殖技术:不孕症患者的一线希望。
ACS Omega. 2025 May 23;10(22):22347-22365. doi: 10.1021/acsomega.5c01643. eCollection 2025 Jun 10.
2
Advancements and Challenges in Preimplantation Genetic Testing for Aneuploidies: In the Pathway to Non-Invasive Techniques.非整倍体植入前基因检测的进展与挑战:通向无创技术之路
Genes (Basel). 2024 Dec 17;15(12):1613. doi: 10.3390/genes15121613.